Mounjaro requires lifestyle changes for effective weight management

Dr. Rahul Baxi, a diabetologist from Mumbai, has received many inquiries about Mounjaro, a new weight-loss injection costing between Rs 14,000 and Rs 17,500 per month. The drug is aimed at treating Type 2 diabetes and obesity but requires lifestyle changes for effective results. Dr. Baxi warns that Mounjaro is not a shortcut for weight loss. Without a balanced diet and regular exercise, the medication’s benefits may not be fully realized. He advises that the drug should be used under medical supervision and prescribed to appropriate patients. As interest in Mounjaro grows, reactions on social media are mixed. Some users mention the success of traditional weight-loss methods, like yoga and home-cooked meals. Others are curious about whether they should try the new injection, reflecting a growing conversation around weight management options in healthcare settings. Mounjaro, recently launched in India by Eli Lilly and Company, is the first drug to specifically target both GIP and GLP-1 receptors. It is designed for chronic weight management and should be used alongside diet and exercise for best outcomes.